Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine

被引：11
|
作者：
Winokur, Patricia L. [1 ,2 ]
Patel, Shital M. [3 ,4 ]
Brady, Rebecca [5 ]
Chen, Wilbur H. [6 ]
El-Kamary, Samer S. [6 ]
Edwards, Kathryn [8 ]
Creech, C. Buddy [8 ]
Frey, Sharon
Keitel, Wendy A. [4 ]
Belshe, Robert [9 ]
Walter, Emmanuel [10 ]
Bellamy, Abbie [7 ]
Hill, Heather [7 ]
机构：
[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[2] Iowa City VA Healthcare Syst, Iowa City, IA USA
[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[5] Cincinnati Childrens Hosp, Gamble Program Clin Studies, Cincinnati, OH USA
[6] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA
[7] EMMES Corp, Rockville, MD USA
[8] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA
[9] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA
[10] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2015年 / 212卷 / 04期
基金：
美国国家卫生研究院;
关键词：
H5N1; influenza; vaccine; prime-boost; MEMORY B-CELLS; PANDEMIC INFLUENZA; ANTIGENIC VARIANT; HUMANS;
D O I：
10.1093/infdis/jiv087
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Influenza A(H5N1) vaccination strategies that improve the speed of the immunological response and cross-clade protection are desired. We compared the immunogenicity of a single 15-mu g or 90-mu g dose of A/H5N1/Indonesia/05/05 (clade 2) vaccine in adults who were previously primed with A/H5N1/Vietnam/1203/2004 (clade 1) vaccine. High-dose vaccine resulted in significantly higher titers to both clade 1 and 2 antigens. Clade 2 titers were unaffected by the previous dose of clade 1 vaccine. Low-dose priming with a mismatched pandemic influenza A(H5N1) vaccine would improve the rapidity, magnitude, and cross-reactivity of the immunological response following a single high-dose, unadjuvanted, pandemic vaccine.
引用
收藏
页码：525 / 530
页数：6
相关论文
共 50 条
  • [1] Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
    Treanor, JJ
    Campbell, JD
    Zangwill, KM
    Rowe, T
    Wolff, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13): : 1343 - 1351
  • [2] An inactivated subvirion influenza A (H5N1) vaccine
    Focosi, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (25): : 2724 - 2725
  • [3] Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans
    Zangwill, Kenneth M.
    Treanor, John J.
    Campbell, James D.
    Noah, Diana L.
    Ryea, Jennifer
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (04): : 580 - 583
  • [4] Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine
    Beigel, John H.
    Voell, Jocelyn
    Huang, Chiung-yu
    Burbelo, Peter D.
    Lane, H. Clifford
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (04): : 501 - 509
  • [5] A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses
    Hoelscher, Mary A.
    Singh, Neetu
    Garg, Sanjay
    Jayashankar, Lakshmi
    Veguilla, Vic
    Pandey, Aseem
    Matsuoka, Yumi
    Katz, Jacqueline M.
    Donis, Ruben
    Mittal, Suresh K.
    Sambhara, Suryaprakash
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (08): : 1185 - 1188
  • [6] Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in Children
    Vajo, Zoltan
    Kosa, Lajos
    Szilvasy, Istvan
    Pauliny, Zsuzsanna
    Bartha, Kalman
    Visontay, Ildiko
    Kis, Agnes
    Tarjan, Ildiko
    Rozsa, Noemi
    Jankovics, Istvan
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (12) : 1052 - 1056
  • [7] An inactivated subvirion influenza A (H5N1) vaccine - Reply
    Poland, GA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (25): : 2725 - 2725
  • [8] Inactivated whole virus influenza A (H5N1) vaccine
    Vajo, Zoltan
    Kosa, Lajos
    Visontay, Ildiko
    Jankovics, Mate
    Jankovics, Istvan
    EMERGING INFECTIOUS DISEASES, 2007, 13 (05) : 807 - 808
  • [9] Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
    Bernstein, David I.
    Edwards, Kathryn M.
    Dekker, Cornelia L.
    Belshe, Robert
    Talbot, Helen K. B.
    Graham, Irene L.
    Noah, Diana L.
    He, Fenhua
    Hill, Heather
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05): : 667 - 675
  • [10] Characterization of a whole, inactivated influenza (H5N1) vaccine
    Tada, Yoshikazu
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2008, 2 (06) : 261 - 266
12345